MAGE-A1 in lung adenocarcinoma as a promising target of chimeric antigen receptor T cells

Table 1 Correlation of high MAGE-A1 protein expression with clinicopathological characteristics in 89 LUAD

Groups	No.	MAGE-A1		χ ²	P value
Groups	No.	+	%	χ ²	P value
Gender
Male	49	28		0.1918	0.661
Female	40	21
Age
≥ 60 years	56	31		0.0055	0.941
< 60 years	33	18
Tumor diameter
≥ 3 cm	56	36		5.1993	0.023*
< 3 cm	33	13
Pathological grade
Grade I–II	64	36		0.1312	0.717
Grade III	25	13
Lymph node metastasis
Positive	48	30		2.3246	0.127
Negative	39	18
Insufficient data	2	1
T status
T1–T2	68	35		1.4974	0.221
T3–T4	21	14
N status
Positive	36	25		4.6647	0.031*
Negative	50	23
Insufficient data	3	1
M status
Positive	1	1		0.8051	0.370
Negative	87	48
Insufficient data	1	0
TNM stage
Stage I–II	44	21		2.3890	0.122
Stage III–IV	42	27
Insufficient data	3	1

ISSN: 1756-8722